Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mortality and Severity in COVID-19 Patients on ACEIs and ARBs—A Systematic Review, Meta-Analysis, and Meta-Regression Analysis
Romil Singh, Sawai Singh Rathore, Hira Khan, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression
Romil Singh, Sawai Singh Rathore, Hira Khan, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 136
Pandemics Throughout the History
Shrikanth Sampath, Anwar Khedr, Shahraz Qamar, et al.
Cureus (2021)
Open Access | Times Cited: 135
Vaccine Development Throughout History
Amr Hany Saleh, Shahraz Qamar, Aysun Tekin, et al.
Cureus (2021)
Open Access | Times Cited: 65
Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021
Safaet Alam, Taslima Binte Kamal, Md. Moklesur Rahman Sarker, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 42
Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective
Wenyue Zheng, Erkang Tian, Zhen Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
The association between early corticosteroid use and the risk of secondary infections in hospitalized patients with COVID-19: a double-edged sword. Results from the international SCCM discovery viral infection and respiratory illness universal study (VIRUS) COVID-19 registry
Vikas Bansal, Nitesh Jain, Amos Lal, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
COVID-19 beyond the lungs: Unraveling its vascular impact and cardiovascular complications—mechanisms and therapeutic implications
Ishita Saha, Oly Banerjee, Shampa Sarkar, et al.
Science Progress (2025) Vol. 108, Iss. 1
Open Access
Prevalence and clinical outcomes of pleural effusion in COVID‐19 patients: A systematic review and meta‐analysis
Sawai Singh Rathore, Nabeel Hussain, Ade Harrison Manju, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 229-239
Open Access | Times Cited: 30
Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
Vasiliki Tsampasian, Natasha Corballis, Vassilios S. Vassiliou
Current Hypertension Reports (2022) Vol. 24, Iss. 10, pp. 425-433
Open Access | Times Cited: 19
Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein
Lingbing Zhang, Yandan Zhang, Xia Qin, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 18
Effect of continuing the use of renin–angiotensin system inhibitors on mortality in patients hospitalized for coronavirus disease 2019: a systematic review, meta-analysis, and meta-regression analysis
Qi Liu, Wei Fu, Changju Zhu, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Severe COVID-19 infection: An institutional review and literature overview
Ogheneyoma Akpoviroro, Nathan Kyle Sauers, Queeneth Uwandu, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0304960-e0304960
Open Access | Times Cited: 2
An umbrella review and meta‐analysis of renin–angiotensin system drugs use and COVID‐19 outcomes
Amanj Kurdi, Tanja Mueller, Natalie Weir
European Journal of Clinical Investigation (2022) Vol. 53, Iss. 2
Open Access | Times Cited: 12
Association of hypothyroidism with outcomes in hospitalized adults with COVID‐19: Results from the International SCCM Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID‐19 Registry
Marija Bogojevic, Vikas Bansal, Vishwanath Pattan, et al.
Clinical Endocrinology (2022) Vol. 101, Iss. 1, pp. 85-93
Open Access | Times Cited: 11
Anticoagulant use before COVID-19 diagnosis prevent COVID-19 associated acute venous thromboembolism or not: A systematic review and meta-analysis
Kinza Iqbal, Akshat Banga, Taha Bin Arif, et al.
World Journal of Methodology (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 1
Timing matters in the use of renin-angiotensin system modulators and COVID-related cognitive and cerebrovascular dysfunction
Mackenzi Meier, Sara J. Becker, Erica Levine, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0304135-e0304135
Open Access | Times Cited: 1
Prevalence and outcomes of upper gastrointestinal bleeding in COVID‐19: A systematic review and meta‐analysis
Sawai Singh Rathore, Zario Wint, Aman Goyal, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 1
Closed Access | Times Cited: 1
Relation Between Renin–Angiotensin–Aldosterone System Inhibitors and COVID-19 Severity
Mousa J Alhaddad, Mohammed S Almulaify, Abdullah A Alshabib, et al.
Cureus (2022)
Open Access | Times Cited: 6
Drugs acting on the renin–angiotensin–aldosterone system (RAAS) and deaths of COVID-19 patients: a systematic review and meta-analysis of observational studies
Ruchika Sharma, Anoop Kumar, Jaseela Majeed, et al.
The Egyptian Heart Journal (2022) Vol. 74, Iss. 1
Open Access | Times Cited: 6
Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses
Ahmed M. Awad, Kamryn Hansen, Diana Del Rio, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1452-1452
Open Access | Times Cited: 2
The effect of renin–angiotensin–aldosterone system inhibitors in patients with hypertension and COVID-19: A meta-analysis of randomized controlled trials and propensity score-matched studies
Kai Zhang, Lanxin Cao, Nanxia Xuan, et al.
Journal of Intensive Medicine (2022) Vol. 2, Iss. 4, pp. 282-290
Open Access | Times Cited: 4
The effects of antihypertensive medications on severity and outcomes of COVID19
Mehmet Ağırbaşlı
Journal of Human Hypertension (2022) Vol. 36, Iss. 10, pp. 875-879
Open Access | Times Cited: 4
Angiotensin receptor blockers could be superior to angiotensin-converting enzyme inhibitors in COVID-19 management: the potential role of bradykinin
Mina Kelleni
Irish Journal of Medical Science (1971 -) (2024) Vol. 193, Iss. 4, pp. 2077-2078
Closed Access
Renin-angiotensin-aldosterone system blockers in Bulgarian COVID-19 patients with or without chronic kidney disease
Rumen Filev, Lionel Rostaing, Mila Lyubomirova, et al.
Medicine (2022) Vol. 101, Iss. 48, pp. e31988-e31988
Open Access | Times Cited: 3
Association of COVID-19 outcomes with diabetes in the Veneto region (north-east italy): Epidemiological insights for the endemic phase?
Francesco Piarulli, Massimo Carollo, Eugenio Ragazzi, et al.
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 33, Iss. 11, pp. 2141-2150
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top